| Autor: |
Piotr Rutkowski, Lubomir Bodnar, Michal Wilk, Dawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, Kamil Kuć, Anna Walerzak, Tomasz Ciszewski, Sylwia Kopeć, Karolina Hryń, Rafał Stec, Cezary Szczylik |
| Jazyk: |
angličtina |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
ESMO Open, Vol 5, Iss 5 (2020) |
| Druh dokumentu: |
article |
| ISSN: |
2059-7029 |
| DOI: |
10.1136/esmoopen-2020-000970 |
| Popis: |
Background Life-threatening diseases have a negative impact on emotional well-being and psychosocial functioning. This study aimed to assess the relationship between the level of anxiety caused by a neoplasm and the threat of coronavirus infection among patients with cancer actively treated with systemic therapy during the COVID-19 pandemic. Additionally, we searched for clinical factors associated with a higher level of anxiety.Methods In this multicentre, prospective, non-interventional study conducted in Poland, we enrolled 306 actively treated patients with cancer and collected their clinical data, including age, gender, cancer type and treatment intention. The fear/anxiety of SARS-CoV-2 were rated in Fear of COVID-19 Scale (SRA-FCV-19S) and Numerical Anxiety Scale (SRA-NAS). The fear and anxiety associated with cancer (CRA) were rated with the NAS (CRA-NAS).Results The mean level of SRA-FCV-19S was 18.5±7.44, which was correlated with the SRA-NAS (r=0.741, p65 years (6.73±2.96 vs 5.66±3.24; p=0.007).Conclusions For an actively treated patient with cancer, cancer remains the main life-threatening disease during the COVID-19 pandemic. The need for more attentive psychological care should be provided especially to female patients, patients with breast cancer, those under 65 years of age and treated with curative intention, as these factors are associated with a higher level of anxiety. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
